Chemoprevention of carcinogenesis in familial tumors

International Journal of Clinical Oncology

Volumn 9, Issue 4, 2004, Pages 299-303

  Ishikawa, Hideki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Colorectal cancer prevention; Familial adenomatous polyposis; Interventional trial

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; EFLORNITHINE; FLUOROURACIL; GREEN TEA EXTRACT; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORNITHINE DECARBOXYLASE INHIBITOR; PLACEBO; ROFECOXIB; SULINDAC;

ADENOMATOUS POLYP; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON CANCER; DRUG EFFICACY; FAMILIAL CANCER; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE PERFORATION; LIFESTYLE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TARGET ORGAN; ULCER;

ADENOMATOUS POLYPOSIS COLI; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; CYCLOOXYGENASE INHIBITORS; DIETARY SUPPLEMENTS; HUMANS; SULINDAC; VITAMINS;

EID: 4644259681     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0417-1     Document Type: Review

References (54)

1. DeCosse JJ, Adams MB, Kuzma JF, et al. (1975) Effect of ascorbic acid on rectal polyps of patients with familial polyposis. Surgery 78:608-612
2. Watne AL, Lai HY, Carrier J, et al. (1977) The diagnosis and surgical treatment of patients with Gardner's syndrome. Surgery 82:327-333
3. Bussey HJ, DeCosse JJ, Deschner EE, et al. (1982) A randomized trial of ascorbic acid in polyposis coli. Cancer 50:1434-1439
4. Waddell WR, Loughry RW (1983) Sulindac for polyposis of the colon. J Surg Oncol 24:83-87
5. Gonzaga RAF, Lima FR, Carneiro S, et al. (1985) Sulindac treatment for familial polyposis coli. Lancet 30:751
6. Lipkin M, Friedman E, Winawer SJ, et al. (1989) Colonic epithelial cell proliferation in responders and nonresponders to supplemental dietary calcium. Cancer Res 49:248-254
7. Itoh H, Iida M, Mibu R, et al. (1989) Local chemotherapy for rectal polyposis: intraluminal administration of 5-fluorouracil for postoperative control of adenomas in the retained rectum in familial polyposis. J Clin Gastroenterol 11:645-649
8. Waddell R, Ganser GF, Cerise EJ, et al. (1989) Sulindac for polyposis of the colon. Am J Surg 157:175-179
9. DeCosse JJ, Miller HH, Lesser ML (1989) Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer Inst 81:1290-1297
10. Charneau J, D'Aubigny N, Burtin P, et al. (1990) Rectal micropolyps after total colectomy for familial polyposis: effectiveness of sulindac therapy. Gastroenterol Clin Biol 14:153-157
11. Friend WG (1990) Sulindac suppression of colorectal polyps in Gardner's syndrome. Am Fam Physician 891-894
12. Stern HS, Gregoire RC, Kashtan H, et al. (1990) Long-term effects of dietary calcium on risk markers for colon cancer in patients with familial polyposis. Surgery 108:528-533
13. Rigau J, Pique JM, Rubio E, et al. (1991) Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 115:952-954
14. Labayle D, Fischer D, Vielh P, et al. (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635-639
15. Thomas MG, Thomson JP, Williamson RC (1993) Oral calcium inhibits rectal epithelial proliferation in familial adenomatous polyposis. Br J Surg 80:499-501
16. Schussheim A, Gold DM, Levine JJ (1993) Sulindac-induced regression of adenomatous colonic polyps in a child with a history of hepatoblastoma. J Pediatr Gastroenterol Nutr 17:445-447
17. Nugent KP, Farmer KCR, Spigelman AD, et al. (1993) Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 80:1618-1619
18. Giardiello FM, Hamilton SR, Krush AJ, et al. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313-1316
19. Tonelli F, Valanzano R (1993) Sulindac in familial adenomatous polyposis. Lancet 342:1120-1121
20. Winde G, Gumbinger HG, Osswald H, et al. (1993) The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration. Int J Colorect Dis 8:13-17
21. Labayle D, Boyer J, Drouhin F, et al. (1994) Sulindac in familial adenomatous polyposis. Lancet 343:417-418
22. Spagnesi MT, Tonelli F, Dolara P, et al. (1994) Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. Gastroenterology 106:362-366
23. Hirata K, Itoh H, Ohsato K (1994) Regression of rectal polyps by indomethacin suppository in familial adenomatous polyposis. Dis Colon Rectum 37:943-946
24. Niv Y, Fraser GM (1994) Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 107: 854-857
25. Lynch HT, Thorson AG, Smyrk T (1995) Rectal cancer after prolonged sulindac chemoprevention. Cancer 75:936-938
26. Debinski HS, Trojan J, Nugent KP, et al. (1995) Effect of sulindac on small polyps in familial adenomatous polyposis. Lancet 345: 855-856
27. Burn J, Mathers CJ, Bertario L, et al. (1995) The protocol for a European double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: the CAPP study. Eur J Cancer 31A: 1385-1386
28. Pasricha PJ, Bedi A, O'Connor K, et al. (1995) The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 109:994-998
29. Winde G, Schmid KW, Schlegel W, et al. (1995) Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Dis Colon Rectum 38:813-830
30. Hirota C, Iida M, Aoyagi K, et al. (1996) Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis. Cancer 78:1660-1665
31. Bertoni G, Sassatelli R, Bedogni G, et al. (1996) Sulindac-associated ulcerative pouchitis in familial adenomatous polyposis. Am J Gastroenterol 91:2431-2432
32. Giardiello FM, Offerhaus JA, Tersmette AC, et al. (1996) Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors. Gut 38: 578-581
33. Nugent KP, Spigelman AD, Phillips RKS (1996) Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac. Dis Colon Rectum 39:659-662
34. Ishikawa H, Akedo I, Suzuki T, et al. (1997) Adverse effects of sulindac used for prevention of colorectal cancer. J Natl Cancer Inst 89:1381
35. Winde G, Schmid KW, Brandt B, et al. (1997) Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis. Dis Colon Rectum 40:1156-1169
36. Koizumi K, Maruyama M, Sakai T, et al. (1997) Clinical features of familial adenomatous polyposis - genotype-phenotype correlation and chemoprevention (in Japanese). Stomach Intestine 32:543-550
37. Kim B, Ninomiya M, Yamane T (1997) Green tea and cancer prevention (in Japanese). Gendai Kagaku. No 9:44-49
38. Ichikawa D, Takahashi T, Adachi T, et al. (1998) Postoperative management of the preserved rectal segment in patients with familial polyposis: the use of 5-fluorouracil suppositories and green tea extract to inhibit tumor growth (in Japanese). Nihon Geka Gakkaishi 99:391-395
39. Ishikawa H, Akedo I, Iseki K, et al. Interventional trial for cancer prevention for familial adenomatous polyposis (1999) In: Utsunomiya J, Mulvihill JJ, Weber BL (eds) Familial cancer and prevention. Wiley-Liss, New York, pp 191-195
40. Keller JJ, Offerhaus GJA, Polak M, et al. (1999) Rectal epithelial apotosis in familial adenomatous polyposis patients treated with sulindac. Gut 45:822-828
41. Steinbach G, Lynch PM, Phillips RKS, et al. (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946-1952
42. Ishikawa H (2001) Cancer prevention in familial cancer. Rinsho Geka 56:617-621
43. Akasu T, Yokoyama T, Sugihara K, et al. (2002) Peroral sustained-release indomethacin treatment for rectal adenomas in familial adenomatous polyposis: a pilot study. Hepatogastroenterology 49: 1259-1261
44. Giardiello FM, Yang VW, Hylind LM, et al. (2002) Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 346:1054-1059
45. Keller JJ, Offerhaus GJA, Hylind LM, et al. (2002) Rectal epithelial apoptosis does not predict response to sulindac treatment or polyp development in presymptomatic familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev 11:670-671
46. Cruz-Correa M, Hylind LM, Romans KE, et al. (2002) Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 122:641-645
47. Sugihara K, Higuchi T, Toyooka M, et al. (2003) A randomized double blind, placebo-controlled study of selective cycooxygenase-2 inhibitor on rectal polyp in familial adenomatous coli. Cancer Sci 95:58
48. Hallak A, Alon-Baron L, Shamir R, et al. (2003) Rofecoxib reduces polyp recurrence in familial polyposis. Dig Dis Sci 48: 1998-2002
49. Giardiello FM, Casero RA, Hamilton SR, et al. (2004) Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis. Gastroenterology 126: 425-431
50. Lynch P (2004) Colorectal cancer prevention study in people with familial adenomatous polyposis. Internet home page http://cancer. gov/clinicaltrials/ft- MDA-ID-0091
51. Kudo T, Narisawa T, Abo S (1980) Antitumor activity of indomethacin on ethylazoxymethanol-induced large bowel tumors in rats. Gann 71:260-264
52. Suh O, Mettlin C, Petrelli NJ. (1993) Aspirin use, cancer, and polyps of the large bowel. Cancer 72:1171-1177
53. Giovannucci E, Rimm EB, Stampfer MJ, et al. (1994) Asprin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121:241-246
54. Matsuhashi N, Nakajima A, Shinohara K, et al. (1998) Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp. Am J Gastroenterol 93:2261-2266